Literature DB >> 15834100

Disappearance of eyelid xanthelasma following oral simvastatin (Zocor).

C L Shields, A Mashayekhi, J A Shields, P Racciato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15834100      PMCID： PMC1772630          DOI： 10.1136/bjo.2004.053058

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

Review 1.  Xanthelasma palpebrarum: a review and current management principles.

Authors:  Rod J Rohrich; Jeffrey E Janis; Patrick H Pownell
Journal:  Plast Reconstr Surg       Date:  2002-10       Impact factor: 4.730

Review 2.  The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention.

Authors:  John A Farmer; Antonio M Gotto
Journal:  Am J Cardiol       Date:  2003-07-03       Impact factor: 2.778

3.  Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS).

Authors:  J M Dumont
Journal:  Control Clin Trials       Date:  1993-06

4.  The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.

Authors:  P Segal; W Insull; L E Chambless; S Stinnett; J C LaRosa; L Weissfeld; S Halfon; P O Kwiterovitch; J A Little
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690
  4 in total
  3 in total

1.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

2.  The Significance of Extracellular Cholesterol Crystals or a Cholesterol Granuloma in Xanthelasma.

Authors:  Frederick A Jakobiec; Lina Ma; Natalie Wolkow; Francis C Sutula; Suzanne K Freitag
Journal:  Ocul Oncol Pathol       Date:  2018-02-21

3.  Rings on the eyes, matters of the heart.

Authors:  Su Mae Ang; Basil K Williams; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.